Peptide Synthesis Market
Report ID: SQMIG35H2313
Report ID: SQMIG35H2313
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35H2313 |
Region:
Global |
Published Date: November, 2024
Pages:
162
|Tables:
119
|Figures:
70
Peptide Synthesis Market size was valued at USD 791.12 Million in 2024 and is poised to grow from USD 893.97 Million in 2025 to USD 2376.57 Million by 2033, growing at a CAGR of 13% during the forecast period (2026–2033).
Peptides serve as signaling molecules that interact with specific receptors located on the cell membrane, initiating intracellular responses that regulate various physiological functions and metabolic processes. In recent years, peptides have gained prominence as potential therapeutic agents due to their improved metabolic stability, specificity for biological targets, and greater binding affinity. It is crucial to recognize that peptide-based therapies differ significantly from small molecule drugs and biologics in aspects such as pharmacological research, analytical and process development, impurity analysis, and structural recognition. The peptide synthesis market has experienced substantial growth in recent years, driven by the rising interest in peptide therapeutics.
Demand for peptide synthesis has increased significantly in the past decade and the approval of peptide-based diagnosis therapy solution has witnessed a spike post pandemic. Presently, more than 80 peptide therapeutics have received approval in various regions worldwide for the treatment of numerous chronic conditions, including cancer, chronic pain, diabetes, HIV, multiple sclerosis, and osteoporosis. Furthermore, since 2015, over 630 clinical trials have been actively undertaken to assess the therapeutic efficacy of peptide-based treatments.
Market snapshot - 2026-2033
Global Market Size
USD 700.11 Million
Largest Segment
personalized therapeutics
Fastest Growth
cardiovascular disease application
Growth Rate
13.0% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Peptide Synthesis Market is segmented by Product & Services, Technology, end user and region. Based on Product & Services, the market is segmented into Reagents, Equipment, Services. Based on Technology, the market is segmented into Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid & Recombinant Technology. Based on end user, the market is segmented into Pharmaceutical & Biotechnology companies, CDMOs & CROs, Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Based on application, the market is segmented into personalized therapeutics, cancer, metabolic, and cardiovascular disorder. The personalized therapeutics segment is dominating the peptide synthesis market with the largest market revenue share. Demand for personalized therapeutic is significantly high due to its extensive treatment of both chronic and non-chronic disease. The demand for personalized therapeutic increased significantly during the pandemic as peptide-based diagnostics and treatment was prevalent. Personalized solutions and personalized medicines have gained significant acceptance in the past couple of years as healthcare expenditure and the need for personalized treatment is on the rise. In addition, many insurance companies are also providing coverage for peptide-based therapeutics solutions, which is also driving market demand.
The cardiovascular disease application segment is expected to witness higher growth during the forecast period. Cardiovascular disease is one of the most prevalent diseases among the adult population and the largest cause of death. In 2021 cardiovascular disease caused more than 20 million deaths globally and accounted for almost one third of all deaths annually. Longer working hours, sedentary lifestyle, lack of sleep and poor diets are some of the major factors causing cardiovascular diseases. Peptide base biomarkers and therapeutic agents are being widely used in the diagnostic and prevention of cardiovascular disease. Vasoactive peptides are the most used peptides used in the modulation of cardiovascular disease.
In terms of end-use the demand for peptide synthesis is segmented into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes. The demand for peptide systems is the largest for pharmaceutical & biotechnology. The financial resources at the disposal of big pharma and biotech companies have increased steadily in the past decade. As a result, these companies have access to labs, cutting edge technology, and infrastructure is significantly high. In addition, the adoption of technology among pharmaceutical and biotechnology companies has also increase post pandemic and the use of peptide for imaging and diagnosis is also growing considerably and this trend is expected to continue during the forecast.
The demand for peptide synthesis is expected to grow the fastest for contract research organization end-use, during the forecast period. The number of contract research organizations has grown substantially in the developed economies and in the Asia-Pacific countries. Availability of skilled resources and funding is growing for contract research organizations. In addition, the market has witnessed a high degree of collaboration between the big pharma companies, government agencies and the contract research organization are boosting the demand for this end-use segment. The collaborations are also increasing the funding available at the disposable of the contract research organizations.
To get detailed segments analysis, Request a Free Sample Report
North America is dominating the global peptide synthesis market due to higher healthcare expenditure and developed healthcare service offerings. North America is home to some of the largest pharmaceutical companies in the world. These players are investing significantly in R&D with the cumulative R&D cost of the pharmaceutical companies in the US accounting to more than USD 95 billion in 2023. The increasing prevalence of chronic diseases in North America is also increasing the demand for peptide synthesis in the region. In the US, more than half of the adult population was reported to suffer from at least one chronic disease.
Demand for peptide synthesis is expected to grow the fastest in the Asia Pacific region. Asia Pacific region is the hub of contract manufacturing for pharmaceutical companies. Developing companies in the region such as China and India are investing significantly on providing facility and infrastructure for contract manufacturing. In addition, availability of trained human resources and the cheaper cost involved in approval and development of peptide synthesis is expected to fuel the demand for market during the forecast period. Growing healthcare budget and improving healthcare insurance coverage in developing economies in the region is also driving the end use demand.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Demand for Imaging Based Diagnosis
Increasing Acceptance of Personalized Medicine and Therapeutics
Lack of Standardization
Strict Regulatory Framework
Request Free Customization of this report to help us to meet your business objectives.
Peptide synthesis is a capital extensive business with a high entry barrier in terms of regulations and approvals. The market is dominated by major global players with many contract manufacturing companies expanding their operations in developing regions due to the low production cost advantages. Companies are spending significant resources on development and approval of new peptide based diagnostic and therapeutic products. Hence R&D initiatives and technology collaborations are the key business strategies witnessed in the market.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global peptide synthesis market is extremely opportunistic and competitive due to higher growth potential in terms of technology and product development. Peptide synthesis is a capital extensive market with major players investing significant resources in R&D and FDA approvals. The developing economies are investing more in contract manufacturing of peptide-based solutions.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 791.12 Million |
| Market size value in 2033 | USD 2376.57 Million |
| Growth Rate | 13% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Peptide Synthesis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Peptide Synthesis Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Peptide Synthesis Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Peptide Synthesis Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
